CTOs on the Move

OmniSYS

www.omnisys.com

 
OmniSYS is a technology company with 25+ years of experience working with pharmacies, payers, providers and pharmaceutical manufacturers. We leverage this unique market insight along with our pharmacy workflow expertise to deliver valuable solutions that help pharmacies thrive in the changing pharmacy landscape. Our solutions help pharmacies engage patients, grow clinical services and improve financial performance. OmniSYS currently serves over 25,000 pharmacies, connects to hundreds of payers and touches millions of patient lives.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.omnisys.com
  • 15950 Dallas Parkway Suite 350
    Dallas, TX USA 75248
  • Phone: 214.459.2574

Executives

Name Title Contact Details

Similar Companies

Prospect Medical Holdings

Prospect Medical Holdings is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Micromedics

Micromedics is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Siskin Hospital for Physical Rehabilitation

Siskin Hospital was founded in 1989 as the first freestanding, not-for-profit rehabilitation hospital in Tennessee built specifically for rehabilitation patients. Currently, Siskin Hospital remains as the only not-for-profit rehabilitation hospital in Tennessee, offering an all-inclusive campus, as well as off-campus locations, dedicated to meeting a wide variety of rehabilitation needs. Siskin Hospital offers all private patient rooms and has specialized Inpatient treatment programs in brain injury, amputation, stroke, spinal cord injury, orthopedics, neurological disorders, and major multiple trauma, among other illnesses and disorders.

ZERO - The End of Prostate Cancer

ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.